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Commentary 
Oral cancer is ranked as the sixth most common malignancy in South Asia – with nearly 300,000 new 
cases diagnosed each year, accounting for one third of the total cancer burden in India.1 Tobacco 
and alcohol consumption are the most significant risk factors for oral cancer world-wide, however, in 
South Asia smokeless tobacco (SLT) accounts for a greater attributable risk.2 Smokeless tobacco is 
any form of tobacco consumed through the mouth or nose that does not involve burning the 
product - this includes betel quid, paan, gutkha, chewing tobacco and other such products. While 
only 1.6% of men and 0.5% of women in the United Kingdom use SLT,3 90% of SLT use is 
concentrated in South Asia4 with the practice viewed as being socially and culturally acceptable.5  
Oral potentially malignant disorders (OPMDs) are clearly defined in this study as any chronic lesion / 
condition found in the mouth that have the potential to transform into oral cancer;6 this includes: 
leukoplakia, erythroplakia, oral sub-mucous fibrosis (OSMF), lichen planus, actinic keratosis, discoid 
lupus erythematosus and palatal lesions among reverse smokers.7 The prevalence of OPMDs 
worldwide ranges from 1 to 5%;8 and their potential for them to undergo malignant transformation 
ranges from 1 to 36%, depending on the subtype of OPMD.9 This study seeks to quantify the risk 
associated with SLT use and the development of OPMDs in South Asia.7 
Fifteen articles corresponding to eighteen studies, pertaining to three of the seven countries in 
South Asia, were included in the meta-analysis. A substantial risk association between SLT use and 
OPMDs was estimated from the pooled data (meta odds ratio, mOR = 15.5; 95% CI, 9.9-24.2). The 
challenge in meta-analysis of published studies is taking into account confounders – analysis of the 
subgroup of studies here that had adjusted for smoking and alcohol found limited attenuation with a 
high-risk association remaining (mOR 13.1; 95%CI 8.3-20.7). OSMF was the found to have the highest 
risk association with SLT use (mOR= 20.0; 95% CI, 12.3-32.5), and leukoplakia the lowest (mOR 4.33; 
95%CI 1.4-13.2). Of the range of SLT products included, betel quid with tobacco carried the highest 
risk association for developing OPMDs (mOR = 16.1; 95% CI, 7.8-33.5); and women were found to 
have a higher risk association (mOR = 22.2; 95% CI, 9.1-54.1) than men (mOR = 8.7; 95% CI, 2.1-34.8). 
Overall, this was a well conducted systematic review and meta-analysis conforming to the meta-
analysis Of Observational Studies in Epidemiology (MOOSE) reporting guidelines.10 The search 
strategy was thorough, but perhaps could also have included seeking unpublished data or contacting 
authors. The reviewers assessed the quality of the included studies using the National Collaborating 
Centre for Methods and Tools, McMaster University’s “Effective Public Health Practice Project 
Quality Assessment Tool for Quantitative Studies”7, and this identified one of the major limitations 
of this meta-analysis – i.e. the quality of included studies were either of moderate (n=12) or weak 
(n=6) quality;7 no studies were found to have strong qualities when assessed. Moreover, the 
quantification of SLT exposure in these studies was also identified by the authors as a problem and 
limitation – particularly the lack of a clear definition for “ever” exposure may cause over estimation 
of the true risk as an individual who has used SLT once was categorised in the same group as 
someone who used SLT for 20 years.7 
This review is a good baseline description of the extent of epidemiological research into SLT and 
OPMD risk in South Asia. It points to the need for further research into this risk association, and 
indeed for the risk associations between SLT, OPMD and oral cancer. However, more importantly, it 
highlights the importance for research into SLT cessation in Asian populations and communities as a 
means to prevent oral cancer worldwide. 
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